Literature DB >> 19059698

Expression of Aurora kinase A and B in normal and malignant cervical tissue: high Aurora A kinase expression in squamous cervical cancer.

Nae-Fang Twu1, Chiou-Chung Yuan, Ming-Shyen Yen, Chiung-Ru Lai, Kuan-Chong Chao, Peng-Hui Wang, Hua-Hsi Wu, Yi-Jen Chen.   

Abstract

OBJECTIVE: Aurora kinases such as Aurora A and B are key regulators of mitosis and tumorigenesis and have been reported to be overexpressed in various malignancies. However, the expression of Aurora kinases in normal and neoplastic cervical tissues remains undetermined. STUDY
DESIGN: Immunohistochemical expression of Aurora A and B kinase was examined in 20 normal cervix, 35 cervical intraepithelial neoplasm 3 (CIN 3) and 95 cervical cancers, including squamous cell carcinoma (SCC) (n=76) and adenocarcinoma (AC) (n=19). Expression of Aurora A and B kinase was confirmed by Western blot. The correlation between Aurora A and B kinases expression and the clinico-pathological parameters was analyzed by statistical analysis.
RESULTS: The Aurora A and B expression was significantly increased in carcinoma and CIN 3, compared with normal cervix. However, expression of Aurora A and B showed no significant correlation between CIN 3 and cervical cancer. The nuclear expression of Aurora A showed a significantly positive correlation with the expression of Aurora B (P=0.018). The percentage of Aurora A overexpression between SCCs and ACs showed a significant difference (50% vs. 21.1%, P=0.023). However, there was no correlation of Aurora A and B expression with patient survival.
CONCLUSION: According to our study, Aurora A and B overexpression is a relatively early phenomenon in the genesis of malignant epithelial neoplasm tumorigenesis. Based on the results of this study, it would be interesting to know whether Aurora kinases play a role in pathogenesis of cervical dysplasia and SCC patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059698     DOI: 10.1016/j.ejogrb.2008.09.012

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  15 in total

1.  Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells.

Authors:  Jian-Ming Sun; Li-Na Yang; Han Xu; Bin Chang; Hua-Ying Wang; Gong Yang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Network analysis revealed aurora kinase dysregulation in five gynecological types of cancer.

Authors:  Shikha Suman; Ashutosh Mishra
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

3.  Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling.

Authors:  Masayuki Komatsu; Kanako Nakamura; Takashi Takeda; Fumiko Chiwaki; Kouji Banno; Daisuke Aoki; Fumitaka Takeshita; Hiroki Sasaki
Journal:  Oncogene       Date:  2022-03-07       Impact factor: 9.867

4.  Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.

Authors:  Yi-Jen Chen; Chun-Ming Chen; Nae-Fang Twu; Ming-Shyen Yen; Chiung-Ru Lai; Hua-Hsi Wu; Peng-Hui Wang; Chiou-Chung Yuan
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

Review 5.  Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

Authors:  Juan-Manuel Schvartzman; Rocio Sotillo; Robert Benezra
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

6.  The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma.

Authors:  Lkhagva-Ochir Tovuu; Tohru Utsunomiya; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Yusuke Arakawa; Hiroki Mori; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Yu Saito; Shinichiro Yamada; Michihito Asanoma; Mitsuo Shimada
Journal:  Int J Clin Oncol       Date:  2013-07-27       Impact factor: 3.402

7.  Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage.

Authors:  Min Jeong Chun; Soo Kyung Hwang; Hyoun Geun Kim; Sung-Ho Goh; Sunshin Kim; Chang-Hun Lee
Journal:  FEBS Open Bio       Date:  2016-06-08       Impact factor: 2.693

Review 8.  Aurora kinases: novel therapy targets in cancers.

Authors:  Anqun Tang; Keyu Gao; Laili Chu; Rui Zhang; Jing Yang; Junnian Zheng
Journal:  Oncotarget       Date:  2017-04-04

9.  Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis.

Authors:  Yuhua Ma; Jie Yang; Ruozheng Wang; Zegao Zhang; Xiaoli Qi; Chunhua Liu; Miaomiao Ma
Journal:  Oncotarget       Date:  2017-05-09

Review 10.  Aurora-A Kinase as a Promising Therapeutic Target in Cancer.

Authors:  Antonino B D'Assoro; Tufia Haddad; Evanthia Galanis
Journal:  Front Oncol       Date:  2016-01-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.